Found 11 results

Name Type of Offering Accepted Date
Neos Therapeutics, Inc. See All Filings
D/A 2009-11-20
Amount To Be Raised $50,000,000
Associated Brokers / Dealers N/A
CIK Number 0001467652
Filed Document 0001467652-09-000006
Exclusions or Exemptions N/A
Accepted Date 2009-11-20
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Neos Therapeutics, Inc. See All Filings
D/A 2009-10-06
Amount To Be Raised $40,000,000
Associated Brokers / Dealers N/A
CIK Number 0001467652
Filed Document 0001467652-09-000004
Exclusions or Exemptions N/A
Accepted Date 2009-10-06
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Neos Therapeutics, Inc. See All Filings
D 2014-01-02
Amount To Be Raised $15,000,000
Associated Brokers / Dealers N/A
CIK Number 0001467652
Filed Document 0001467652-14-000001
Exclusions or Exemptions 506b
Accepted Date 2014-01-02
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Neos Therapeutics, Inc. See All Filings
D 2011-06-07
Amount To Be Raised $20,000,000
Associated Brokers / Dealers N/A
CIK Number 0001467652
Filed Document 0001467652-11-000001
Exclusions or Exemptions N/A
Accepted Date 2011-06-07
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Neos Therapeutics, Inc. See All Filings
D/A 2014-03-04
Amount To Be Raised $15,500,170
Associated Brokers / Dealers N/A
CIK Number 0001467652
Filed Document 0001467652-14-000002
Exclusions or Exemptions 506b
Accepted Date 2014-03-04
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Neos Therapeutics, Inc. See All Filings
D 2009-07-01
Amount To Be Raised $40,000,000
Associated Brokers / Dealers N/A
CIK Number 0001467652
Filed Document 0001467652-09-000002
Exclusions or Exemptions N/A
Accepted Date 2009-07-01
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Neos Therapeutics, Inc. See All Filings
D 2014-04-09
Amount To Be Raised $2,500,000
Associated Brokers / Dealers N/A
CIK Number 0001467652
Filed Document 0001467652-14-000003
Exclusions or Exemptions 506b
Accepted Date 2014-04-09
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Neos Therapeutics, Inc. See All Filings
D 2015-01-06
Amount To Be Raised $15,000,000
Associated Brokers / Dealers N/A
CIK Number 0001467652
Filed Document 0001467652-15-000001
Exclusions or Exemptions 506b
Accepted Date 2015-01-06
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Neos Therapeutics, Inc. See All Filings
D/A 2009-10-06
Amount To Be Raised $40,000,000
Associated Brokers / Dealers N/A
CIK Number 0001467652
Filed Document 0001467652-09-000005
Exclusions or Exemptions N/A
Accepted Date 2009-10-06
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Neos Therapeutics, Inc. See All Filings
D 2012-07-16
Amount To Be Raised $30,000,000
Associated Brokers / Dealers N/A
CIK Number 0001467652
Filed Document 0001467652-12-000001
Exclusions or Exemptions N/A
Accepted Date 2012-07-16
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity
Neos Therapeutics, Inc. See All Filings
D/A 2015-02-19
Amount To Be Raised $20,624,355
Associated Brokers / Dealers N/A
CIK Number 0001467652
Filed Document 0001467652-15-000003
Exclusions or Exemptions 506b
Accepted Date 2015-02-19
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business TEXAS
Revenue or Assets Decline to Disclose
Type of Security Equity